To evaluate whether the presence of FBN1 variants influences the expression of genes related to the TGFβ2 pathway, patients with Marfan syndrome were stratified into two groups: those with identified FBN1 mutations (MFS-Variants) and those without genetic testing (MFS-TNP). The gene discussed is TGFB2; the disease is Marfan syndrome.